New Glaucoma Surgery

Published Online: Thursday, May 17, 2012
Follow Pharmacy_Times:
In this podcast, Mayo Clinic ophthalmologist Rajesh Shetty, MD, discusses the symptoms and causes of and treatments for glaucoma. He touches on risk factors for the condition, including the propensity for certain ethnic groups to develop the disease, as well as the effect of one's family history on the likelihood of developing it. Treatment can include eye drops and laser treatment, according to Dr. Shetty. In cases where eye drops or lasers do not relieve pressure, Dr. Shetty explains other surgical options as well as their potential complications. He also explains potential side effects of drugs such as blood thinners. He also explains a newer approach, called the Trabectome procedure, which opens the eye’s internal drain by cleaning it. Although the procedure can reduce pressure, Dr. Shetty explains that many patients need to continue eye drop therapy even after undergoing it.
 
To download the podcast, click here.
Related Articles
Latanoprostene bunod (Vesneo) demonstrated noninferiority to timolol maleate (Timoptic 5%) in pivotal Phase 3 studies.
Selenium and vitamin E supplementation will not prevent cataracts in men, a new study suggests.
Galleon Pharmaceuticals Corp's GAL-021 reverses and prevents respiratory depression associated with opioid use without affecting analgesia.
Mylan, Inc, has launched a therapeutically equivalent version of Precedex, while Hospira, Inc, has filed a lawsuit to challenge the generic approval.
Latest Issues
$auto_registration$